{"log_id": 2320815908474060562, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 0.02531, "average": 0.873118, "min": 0.446548}, "location": {"width": 675, "top": 107, "height": 54, "left": 258}, "words": "缝而脱皮导影干拔或中断多齿地赛治疗(见【用法用量】"}, {"probability": {"variance": 0.004787, "average": 0.929515, "min": 0.835351}, "location": {"width": 109, "top": 169, "height": 32, "left": 258}, "words": "体潴留"}, {"probability": {"variance": 0.022315, "average": 0.908082, "min": 0.420976}, "location": {"width": 918, "top": 213, "height": 59, "left": 309}, "words": "患可能发生重度体液潴留,应密切注意如胸膜枳液,心包积液及水的发生"}, {"probability": {"variance": 0.016892, "average": 0.944044, "min": 0.577822}, "location": {"width": 247, "top": 268, "height": 43, "left": 252}, "words": "肝功能有损害的法者"}, {"probability": {"variance": 0.023683, "average": 0.920839, "min": 0.447418}, "location": {"width": 1195, "top": 316, "height": 66, "left": 304}, "words": "使用多西他单药治疗100mg/m3剂量的患者,如果血清氨基转移酶ALT和/或AST超过1.5倍正常值"}, {"probability": {"variance": 0.006586, "average": 0.960499, "min": 0.56196}, "location": {"width": 1244, "top": 343, "height": 68, "left": 252}, "words": "上限,同时伴有碱性磷酸酶超过2.5倍正常值上限,发生重度不良反应的危性升高,如因毒性死亡,包"}, {"probability": {"variance": 0.027544, "average": 0.92198, "min": 0.371235}, "location": {"width": 1253, "top": 364, "height": 77, "left": 245}, "words": "括致死的轮毒症和胃肠道出血,发热性中性粒细胞减少症,感染,血小板减少症,口腔炎乏力。因"}, {"probability": {"variance": 0.016812, "average": 0.931848, "min": 0.553431}, "location": {"width": 272, "top": 400, "height": 43, "left": 249}, "words": "此,这些肝功能化验值"}, {"probability": {"variance": 0.02289, "average": 0.902796, "min": 0.566134}, "location": {"width": 245, "top": 430, "height": 36, "left": 249}, "words": "期前要检洲肝功能("}, {"probability": {"variance": 0.022535, "average": 0.914923, "min": 0.382049}, "location": {"width": 494, "top": 412, "height": 52, "left": 636}, "words": "升高的患者:其多西他的推荐剂量为75"}, {"probability": {"variance": 0.016599, "average": 0.896872, "min": 0.658809}, "location": {"width": 194, "top": 435, "height": 36, "left": 595}, "words": "见【用法用量j"}, {"probability": {"variance": 0, "average": 0.998892, "min": 0.998892}, "location": {"width": 16, "top": 442, "height": 25, "left": 586}, "words": "("}, {"probability": {"variance": 0.003341, "average": 0.95971, "min": 0.807617}, "location": {"width": 297, "top": 426, "height": 45, "left": 1202}, "words": "3,并且在基线和每个周"}, {"probability": {"variance": 0.021902, "average": 0.90796, "min": 0.425208}, "location": {"width": 1193, "top": 474, "height": 68, "left": 300}, "words": "当思者血浩胆红第正常值上阳且/ALT及AST>3.5倍正常值上限伴血清碱性璘酸酶>E倍正常值上"}, {"probability": {"variance": 0.004148, "average": 0.964111, "min": 0.712054}, "location": {"width": 760, "top": 499, "height": 57, "left": 242}, "words": "限,除非有严格的使用指证,否则不应使用,也无减量使用建议"}, {"probability": {"variance": 0.023744, "average": 0.931696, "min": 0.3966}, "location": {"width": 705, "top": 547, "height": 52, "left": 297}, "words": "目前尚无严肝功能害患者使用多西他赛联合用药的资料"}, {"probability": {"variance": 0.003265, "average": 0.964354, "min": 0.842301}, "location": {"width": 249, "top": 602, "height": 38, "left": 240}, "words": "肾功能有损害的患者"}, {"probability": {"variance": 0.019859, "average": 0.922684, "min": 0.552842}, "location": {"width": 595, "top": 648, "height": 50, "left": 297}, "words": "日前尚无严年肾功能损害思者使用多西他赛的资料"}, {"probability": {"variance": 2e-06, "average": 0.998966, "min": 0.996682}, "location": {"width": 116, "top": 703, "height": 34, "left": 235}, "words": "神经系统"}, {"probability": {"variance": 0.010041, "average": 0.954515, "min": 0.607354}, "location": {"width": 946, "top": 744, "height": 68, "left": 288}, "words": "当观景到重度外周神经毒性症状时,应减少多西他赛的剂量(见【用法用量】"}, {"probability": {"variance": 0.0339, "average": 0.883307, "min": 0.565111}, "location": {"width": 112, "top": 806, "height": 29, "left": 233}, "words": "心脏毒性"}, {"probability": {"variance": 0.018891, "average": 0.92027, "min": 0.52837}, "location": {"width": 1189, "top": 845, "height": 73, "left": 288}, "words": "在接受多西他赛联台曲妥珠单抗治疗的患者中,持别是在含环类药物治疗(阿霉素成表阿素"}, {"probability": {"variance": 0.012738, "average": 0.947949, "min": 0.508585}, "location": {"width": 998, "top": 872, "height": 66, "left": 229}, "words": "后,观察到心力衰竭发生,可能是中度至重度的,井可能导致死亡(见【不良反应】"}, {"probability": {"variance": 0.00949, "average": 0.964457, "min": 0.434743}, "location": {"width": 1186, "top": 916, "height": 73, "left": 288}, "words": "当玉准备接受多西他赛联合曲妥珠单抗治疗时,应对其基础心脏状况进行评估。在治疗期间应继"}, {"probability": {"variance": 0.010978, "average": 0.947086, "min": 0.602086}, "location": {"width": 1253, "top": 943, "height": 75, "left": 222}, "words": "续监测心脏功能「如每3个月1,有助于确诊患者是否发生心脏机能紊乱。更多的详情见曲妥珠单抗说"}, {"probability": {"variance": 0, "average": 0.910842, "min": 0.910842}, "location": {"width": 57, "top": 978, "height": 27, "left": 226}, "words": "明"}, {"probability": {"variance": 0, "average": 0.999249, "min": 0.998641}, "location": {"width": 38, "top": 1085, "height": 29, "left": 1404}, "words": "21"}, {"probability": {"variance": 0.05064, "average": 0.774913, "min": 0.549879}, "location": {"width": 112, "top": 1195, "height": 82, "left": 1136}, "words": "水康"}, {"probability": {"variance": 1e-06, "average": 0.999337, "min": 0.997918}, "location": {"width": 116, "top": 1269, "height": 32, "left": 219}, "words": "乙醇含量"}, {"probability": {"variance": 0.011546, "average": 0.953773, "min": 0.503902}, "location": {"width": 1186, "top": 1310, "height": 73, "left": 274}, "words": "多西他赛注射液的配方中含有无水乙醇,国外有报道配酒发生。在多西他赛注射液单药使用中,其"}, {"probability": {"variance": 0.008622, "average": 0.960716, "min": 0.513487}, "location": {"width": 1241, "top": 1337, "height": 73, "left": 217}, "words": "乙醇成分有可能影响中枢神经系统,不能或不宜饮酒的思者应谨慎使用多西他赛。由于多西赛含有乙"}, {"probability": {"variance": 0.008886, "average": 0.952551, "min": 0.562056}, "location": {"width": 1250, "top": 1370, "height": 71, "left": 210}, "words": "酵成分,在注射给药后不应立即驾驶或操作器械。患者每次输江多西他注射液100mg/m即获得乙醇"}, {"probability": {"variance": 0.014864, "average": 0.94485, "min": 0.436188}, "location": {"width": 1250, "top": 1399, "height": 73, "left": 208}, "words": "2.0g/m。若某患者体表面积为2.0/m2,则单次注射多西他赛注射液后获得40g乙醇国内外多西他赛注"}, {"probability": {"variance": 0.01134, "average": 0.959437, "min": 0.610878}, "location": {"width": 332, "top": 1431, "height": 34, "left": 213}, "words": "射液所含乙醇含量或有差异"}, {"probability": {"variance": 1e-06, "average": 0.998273, "min": 0.997431}, "location": {"width": 57, "top": 1498, "height": 29, "left": 203}, "words": "其他"}, {"probability": {"variance": 0.002824, "average": 0.982379, "min": 0.740226}, "location": {"width": 655, "top": 1544, "height": 52, "left": 258}, "words": "在治疗期间及治疗结束后至少三个月内应采取避孕措施"}, {"probability": {"variance": 0.023351, "average": 0.953636, "min": 0.403021}, "location": {"width": 421, "top": 1612, "height": 48, "left": 197}, "words": "乳腺辅化疗时的其他注意事项"}, {"probability": {"variance": 0.000132, "average": 0.992312, "min": 0.964756}, "location": {"width": 258, "top": 1654, "height": 45, "left": 194}, "words": "并发中性粒细胞减少"}, {"probability": {"variance": 0.010987, "average": 0.965286, "min": 0.460572}, "location": {"width": 1186, "top": 1699, "height": 73, "left": 256}, "words": "并发中性粒细胞减少的思者(包括中性粒细胞减少发生时间延长,发热性中性粒细胞减少,或感"}, {"probability": {"variance": 0.017821, "average": 0.918704, "min": 0.506369}, "location": {"width": 673, "top": 1727, "height": 54, "left": 192}, "words": "染】,应考虑使用G-CSF及减少剂舞见【用法用量"}, {"probability": {"variance": 0.002274, "average": 0.973822, "min": 0.878498}, "location": {"width": 153, "top": 1784, "height": 41, "left": 190}, "words": "胃肠过反应"}, {"probability": {"variance": 0.003265, "average": 0.974405, "min": 0.724424}, "location": {"width": 1191, "top": 1828, "height": 73, "left": 245}, "words": "早期出现的症状包括:伴或不伴中性粒细胞减少的腹痛及胃浙道敏感,发热,腹泻。早期可能发生"}, {"probability": {"variance": 0.021371, "average": 0.936192, "min": 0.391993}, "location": {"width": 501, "top": 1853, "height": 54, "left": 185}, "words": "严重胃道毒性反应,应迅速诊断及治疗"}, {"probability": {"variance": 0.032894, "average": 0.84771, "min": 0.556189}, "location": {"width": 206, "top": 1915, "height": 34, "left": 185}, "words": "充血性心力衰竭"}, {"probability": {"variance": 0.004442, "average": 0.781088, "min": 0.714441}, "location": {"width": 151, "top": 1915, "height": 50, "left": 1294}, "words": "性乐"}, {"probability": {"variance": 0.028578, "average": 0.918855, "min": 0.413006}, "location": {"width": 1269, "top": 1956, "height": 73, "left": 238}, "words": "在治疗及随访期间,应对患充血性心衰的症状进行监测。在接受TAC治疗的巴结阳性乳腺痛一"}, {"probability": {"variance": 0.015235, "average": 0.949481, "min": 0.530946}, "location": {"width": 449, "top": 1984, "height": 52, "left": 180}, "words": "者中观察到治疗后第一年的CHF较高"}, {"probability": {"variance": 0.014627, "average": 0.904454, "min": 0.733803}, "location": {"width": 84, "top": 2045, "height": 32, "left": 183}, "words": "白血病"}, {"probability": {"variance": 0.028928, "average": 0.914923, "min": 0.447137}, "location": {"width": 1200, "top": 2082, "height": 82, "left": 229}, "words": "接受多西他赛,阿霉素及环磷酰胺TAC1的患老中,需要对发生迟发型脊髓发育不良性岛"}, {"probability": {"variance": 0.000375, "average": 0.991652, "min": 0.927402}, "location": {"width": 368, "top": 2116, "height": 45, "left": 176}, "words": "血病的危险性进行血液学随访"}, {"probability": {"variance": 0.05364, "average": 0.553182, "min": 0.357611}, "location": {"width": 304, "top": 2220, "height": 45, "left": 1163}, "words": "武手月"}], "language": 3}